Search research articles
Contact Us
Filters
Showing results (111-120 of 222) with videos related to
Page
of 23
Sort By:
Lakartidningen
|
April 3, 1991
[Report myelodysplastic syndrome to the cancer registry!]
A Osterborg, P Reizenstein, E Hellström
Blut
|
October 1, 1985
Remission with high erythrocyte sedimentation rates in acute myeloid leukemia is of short duration
A Brizzi, C Ogier, P Reizenstein
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg
|
March 1, 1989
Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapy
G Mathé, P Reizenstein, M Eriguchi
Scandinavian Journal of Clinical and Laboratory Investigation
|
November 1, 1975
Total body potassium measurements in 230 patients. A study of potassium depletion
B Carlmark, D Kromhout, P Reizenstein
Leukemia & Lymphoma
|
July 27, 2016
Effect of Cytotoxic Cells on Minimal Residual Leukemia
A Porwit, K Palucka, P Reizenstein
International Journal of Cancer
|
February 15, 1988
D-verapamil and L-verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro
A Gruber, C Peterson, P Reizenstein
Lakartidningen
|
January 7, 1987
[Solvents and non-Hodgkin's lymphoma--an investigation of a case of occupational disease]
M Ahman, R Alexandersson, P Reizenstein
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1988
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors
M Musset, G Mathé, P Reizenstein
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Decreased retention of vinca alkaloids in chronic lymphatic leukemia cells from refractory patients
M Beksac, C Peterson, P Reizenstein
Acta Medica Scandinavica
|
January 1, 1979
Electrolytes and whole body potassium in acute leukemia
B Lantz, B Carlmark, P Reizenstein
Page
of 23
Search research articles
Search
Showing results (111-120 of 222) with videos related to
Sort By:
Page
of 23
Lakartidningen
|
April 3, 1991
[Report myelodysplastic syndrome to the cancer registry!]
A Osterborg, P Reizenstein, E Hellström
Blut
|
October 1, 1985
Remission with high erythrocyte sedimentation rates in acute myeloid leukemia is of short duration
A Brizzi, C Ogier, P Reizenstein
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg
|
March 1, 1989
Adjuvant treatment of minimal residual tumors. A comparison of chemotherapy and immunotherapy
G Mathé, P Reizenstein, M Eriguchi
Scandinavian Journal of Clinical and Laboratory Investigation
|
November 1, 1975
Total body potassium measurements in 230 patients. A study of potassium depletion
B Carlmark, D Kromhout, P Reizenstein
Leukemia & Lymphoma
|
July 27, 2016
Effect of Cytotoxic Cells on Minimal Residual Leukemia
A Porwit, K Palucka, P Reizenstein
International Journal of Cancer
|
February 15, 1988
D-verapamil and L-verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro
A Gruber, C Peterson, P Reizenstein
Lakartidningen
|
January 7, 1987
[Solvents and non-Hodgkin's lymphoma--an investigation of a case of occupational disease]
M Ahman, R Alexandersson, P Reizenstein
Supplement ... to the Journal Medical Oncology and Tumor Pharmacotherapy
|
January 1, 1988
Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors
M Musset, G Mathé, P Reizenstein
Cancer Chemotherapy and Pharmacology
|
January 1, 1985
Decreased retention of vinca alkaloids in chronic lymphatic leukemia cells from refractory patients
M Beksac, C Peterson, P Reizenstein
Acta Medica Scandinavica
|
January 1, 1979
Electrolytes and whole body potassium in acute leukemia
B Lantz, B Carlmark, P Reizenstein
Page
of 23